OFI INVEST ASSET MANAGEMENT

Position in LLY — ELI LILLY & Co

CIK 1977602 ISSY LES MOULINEAUX, I0

Position in LLY

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$121,273,177

-$122,111,761 QoQ

Shares Held

101,109

-61.8% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

1.11%

of 13F equity value

Holder Rank

#346

of 4,605 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

OFI INVEST ASSET MANAGEMENT holds $330,320,760 across 8 Drug Manufacturers - General names. LLY ranks #1 (36.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	101,109	$121,273,177
2	MRK	Merck & Co., Inc.	569,512	$73,182,292
3	ABBV	AbbVie Inc.	274,288	$69,021,832
4	GILD	Gilead Sciences, Inc.	307,767	$38,883,282
5	PFE	Pfizer Inc	751,408	$18,093,904
6	JNJ	Johnson & Johnson	18,967	$4,817,048
7	AMGN	Amgen Inc	12,932	$4,682,935
8	BMY	Bristol Myers Squibb Co	6,357	$366,290

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$121,273,177	101,109	-61.8%	Shares	Sole	2026-07-17
2026-03-31	$243,384,938	264,615	+114.9%	Shares	Sole	2026-05-05
2025-12-31	$132,313,539	123,119	-9.8%	Shares	Sole	2026-01-22
2025-09-30	$104,149,500	136,500	+11.3%	Shares	Sole	2025-10-14
2025-06-30	$95,583,630	122,617	-5.6%	Shares	Sole	2025-07-25
2025-03-31	$107,288,186	129,903	-10.2%	Shares	Sole	2025-05-09
2024-12-31	$111,698,364	144,687	+28.7%	Shares	Sole	2025-02-07
2024-06-30	$101,769,238	112,405	+25.4%	Shares	Sole	2024-07-19
2024-03-31	$69,731,666	89,634	+4.8%	Shares	Sole	2024-04-29
2023-12-31	$49,858,896	85,533	-24.5%	Shares	Sole	2024-02-14
2023-09-30	$60,850,383	113,288	-21.8%	Shares	Sole	2023-11-02
2023-06-30	$67,954,264	144,898	-99.7%	Shares	Sole	2023-07-31
2023-03-31	$154,433	53,035,381	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.